Litcius/Paper detail

Clinical Efficacy of Intravenous Immunoglobulins in Management of Toxic Shock Syndrome: An Updated Literature Review

Sana Amreen, Simrandeep K Brar, Sumera Perveen, Muhammad Reza Chaudhry, Sarah Albabtain, Safeera Khan

2021Cureus16 citationsDOIOpen Access PDF

Abstract

Toxic shock syndrome (TSS) is an uncommon complication of infection caused by streptococci and staphylococci. It is associated with a high mortality rate. When evaluating patients with shock symptoms from skin or soft tissue sources, a high index of suspicion for TSS must be maintained. Prompt diagnosis and integrative management with surgical intervention, antibiotics, hemodynamic stabilization, and adjuvants like intravenous immunoglobulins improve survival.

Topics & Concepts

Intravenous ImmunoglobulinsMedicineAntibodyShock (circulatory)Intensive care medicineImmunologyInternal medicineStreptococcal Infections and TreatmentsAntimicrobial Resistance in StaphylococcusRabies epidemiology and control
Clinical Efficacy of Intravenous Immunoglobulins in Management of Toxic Shock Syndrome: An Updated Literature Review | Litcius